1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Brain Tumor Drugs Market, By Therapy
5.1 Introduction
5.2 Targeted Therapy
5.3 Chemotherapy
5.4 Immunotherapy
5.5 Other Therapies
6 Global Brain Tumor Drugs Market, By Indication
6.1 Introduction
6.2 Pituitary Tumors
6.3 Meningioma
6.4 Glioblastoma
6.5 Glioma
7 Global Brain Tumor Drugs Market, By Drugs
7.1 Introduction
7.2 Bevacizumab
7.3 Temozolomide
7.4 Other Drugs
8 Global Brain Tumor Drugs Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 F. Hoffmann-La Roche Ltd
10.2 Merck & Co. Inc.
10.3 Pfizer Inc
10.4 Novartis AG
10.5 Amneal Pharmaceuticals LLC.
10.6 NextSource Pharmaceuticals, LLC
10.7 Amgen Inc
10.8 Bristol-Myers Squibb
10.9 Emcure Pharmaceuticals
10.10 AstraZeneca
List of Tables
Table 1 Global Brain Tumor Drugs Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 3 Global Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 4 Global Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 5 Global Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 6 Global Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 7 Global Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 8 Global Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 9 Global Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 10 Global Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 11 Global Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 12 Global Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 13 Global Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 14 Global Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 15 Global Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
Table 16 North America Brain Tumor Drugs Market Outlook, By Country (2020-2028) ($MN)
Table 17 North America Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 18 North America Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 19 North America Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 20 North America Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 21 North America Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 22 North America Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 23 North America Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 24 North America Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 25 North America Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 26 North America Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 27 North America Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 28 North America Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 29 North America Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 30 North America Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
Table 31 Europe Brain Tumor Drugs Market Outlook, By Country (2020-2028) ($MN)
Table 32 Europe Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 33 Europe Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 34 Europe Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 35 Europe Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 36 Europe Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 37 Europe Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 38 Europe Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 39 Europe Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 40 Europe Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 41 Europe Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 42 Europe Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 43 Europe Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 44 Europe Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 45 Europe Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
Table 46 Asia Pacific Brain Tumor Drugs Market Outlook, By Country (2020-2028) ($MN)
Table 47 Asia Pacific Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 48 Asia Pacific Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 49 Asia Pacific Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 50 Asia Pacific Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 51 Asia Pacific Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 52 Asia Pacific Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 53 Asia Pacific Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 54 Asia Pacific Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 55 Asia Pacific Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 56 Asia Pacific Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 57 Asia Pacific Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 58 Asia Pacific Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 59 Asia Pacific Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 60 Asia Pacific Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
Table 61 South America Brain Tumor Drugs Market Outlook, By Country (2020-2028) ($MN)
Table 62 South America Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 63 South America Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 64 South America Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 65 South America Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 66 South America Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 67 South America Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 68 South America Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 69 South America Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 70 South America Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 71 South America Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 72 South America Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 73 South America Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 74 South America Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 75 South America Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
Table 76 Middle East & Africa Brain Tumor Drugs Market Outlook, By Country (2020-2028) ($MN)
Table 77 Middle East & Africa Brain Tumor Drugs Market Outlook, By Therapy (2020-2028) ($MN)
Table 78 Middle East & Africa Brain Tumor Drugs Market Outlook, By Targeted Therapy (2020-2028) ($MN)
Table 79 Middle East & Africa Brain Tumor Drugs Market Outlook, By Chemotherapy (2020-2028) ($MN)
Table 80 Middle East & Africa Brain Tumor Drugs Market Outlook, By Immunotherapy (2020-2028) ($MN)
Table 81 Middle East & Africa Brain Tumor Drugs Market Outlook, By Other Therapies (2020-2028) ($MN)
Table 82 Middle East & Africa Brain Tumor Drugs Market Outlook, By Indication (2020-2028) ($MN)
Table 83 Middle East & Africa Brain Tumor Drugs Market Outlook, By Pituitary Tumors (2020-2028) ($MN)
Table 84 Middle East & Africa Brain Tumor Drugs Market Outlook, By Meningioma (2020-2028) ($MN)
Table 85 Middle East & Africa Brain Tumor Drugs Market Outlook, By Glioblastoma (2020-2028) ($MN)
Table 86 Middle East & Africa Brain Tumor Drugs Market Outlook, By Glioma (2020-2028) ($MN)
Table 87 Middle East & Africa Brain Tumor Drugs Market Outlook, By Drugs (2020-2028) ($MN)
Table 88 Middle East & Africa Brain Tumor Drugs Market Outlook, By Bevacizumab (2020-2028) ($MN)
Table 89 Middle East & Africa Brain Tumor Drugs Market Outlook, By Temozolomide (2020-2028) ($MN)
Table 90 Middle East & Africa Brain Tumor Drugs Market Outlook, By Other Drugs (2020-2028) ($MN)
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
